https://www.getnews.info/1359632/parkinson-disease-pipelineclinical-trials-during-the-forecast-period-20232032-key-companies-novide-biopharmaceuticals-roche-pharmaceuticals-centogene-gmbh.html
Parkinson Disease Pipeline|Clinical trials During the Forecast Period (2023-2032)| Key Companies – Novide Biopharmaceuticals, Roche Pharmaceuticals, Centogene GmbH - Digital Journal